Septerna (NASDAQ:SEPN) Now Covered by TD Cowen

TD Cowen assumed coverage on shares of Septerna (NASDAQ:SEPN - Free Report) in a research report report published on Tuesday morning, Marketbeat Ratings reports. The firm issued a buy rating on the stock.

Septerna Price Performance

Septerna stock traded up $0.57 during trading on Tuesday, reaching $24.12. The company had a trading volume of 185,032 shares, compared to its average volume of 199,049. Septerna has a 1-year low of $18.62 and a 1-year high of $26.34.

Insider Activity

In other news, major shareholder Rock Ventures V. L.P. Third acquired 370,500 shares of the firm's stock in a transaction dated Monday, October 28th. The stock was acquired at an average cost of $18.00 per share, with a total value of $6,669,000.00. Following the completion of the acquisition, the insider now owns 6,215,591 shares of the company's stock, valued at $111,880,638. The trade was a 6.34 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Septerna Company Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.